PharmaNutra SpAMIL:PHN +2.42%85 OCF Margin % is 5.90% as of Mar. 2026, which is 67% below its 10-year median of 17.69. GuruFocus rates MIL:PHN with a GF Score™ of 85/100 and a GF Value™ of €71.38 (Modestly Overvalued). The stock has 6 warning signs investors should review. Among 959 Drug Manufacturers companies, PharmaNutra SpA ranks better than 62.67% on this metric.
The historical rank and industry rank for PharmaNutra SpA's OCF Margin % or its related term are showing as below:
MIL:PHN'
s OCF Margin % Range Over the Past 10 Years
Min: 11.92 Med: 17.69 Max: 29.65
Current: 13.94
During the past 11 years, the highest OCF Margin % of PharmaNutra SpA was 29.65%. The lowest was 11.92%. And the median was 17.69%.
MIL:PHN's OCF Margin % is ranked better than 62.67% of 959
companies
in the Drug Manufacturers industry
Industry Median: 9.95
vs MIL:PHN: 13.94
PharmaNutra SpA OCF Margin % Related Terms
PharmaNutra SpA OCF Margin % Historical Data
* Premium members only.
The historical data trend for PharmaNutra SpA's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MIL:PHN vs ZTS, UTHR, VTRS: OCF Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, PharmaNutra SpA's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PharmaNutra SpA OCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, PharmaNutra SpA's OCF Margin % distribution charts can be found below:
* The bar in red indicates where PharmaNutra SpA's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PharmaNutra SpA (MIL:PHN) has a OCF Margin % of 5.90% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on PharmaNutra SpA and its competitors. This is 67% below median its historical median of 17.69. Over the past decade, PharmaNutra SpA's OCF Margin % has ranged from 11.92 to 29.65. According to the industry distribution chart, PharmaNutra SpA ranks #358 out of 959 companies in the Drug Manufacturers industry, placing it in the top 37.3%.
Is PharmaNutra SpA's OCF Margin % too high?
PharmaNutra SpA's current OCF Margin % of 5.90% is 67% below median its 10-year median of 17.69. Over the past 10 years, this metric has ranged from a low of 11.92 to a high of 29.65. The Drug Manufacturers industry median OCF Margin % is 9.95. PharmaNutra SpA's value of 5.90% is 40.7% below this industry median. Based on the distribution chart, PharmaNutra SpA ranks #358 out of 959 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, PharmaNutra SpA has a GF Score™ of 85/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does PharmaNutra SpA's OCF Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, PharmaNutra SpA ranks #358 out of 959 companies for OCF Margin %. This puts PharmaNutra SpA in the upper half of its industry. The industry median OCF Margin % is 9.95. PharmaNutra SpA's value of 5.90% is 40.7% below this benchmark. Historically, PharmaNutra SpA's own OCF Margin % has ranged from 11.92 to 29.65 over the past decade. While the company's 10-year median is 17.69 vs. the industry median of 9.95, PharmaNutra SpA has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 9.95, based on 959 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PharmaNutra SpA's current OCF Margin % of 5.90% is 40.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on PharmaNutra SpA and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 9.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PharmaNutra SpA's current OCF Margin % is 5.90%, which is 67% below median its own 10-year median of 17.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PharmaNutra SpA stock overvalued right now?
Based on GuruFocus' analysis, PharmaNutra SpA (MIL:PHN) is currently considered Modestly Overvalued. The stock's GF Value™ is €71.38, compared to a current price of €88.90 — trading 24.5% above its estimated fair value. The current OCF Margin % is 5.90%, which is 67% below median its 10-year median of 17.69 and 40.7% below the Drug Manufacturers industry median of 9.95. PharmaNutra SpA's overall GF Score™ is 85/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For PharmaNutra SpA (MIL:PHN), the current OCF Margin % is 5.90% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PharmaNutra SpA (MIL:PHN) Overvalued in 2026?
Based on GuruFocus' analysis, PharmaNutra SpA stock appears to be overvalued.
The current stock price of €88.90 is trading 24.5% above its estimated GF Value™ of €71.38.
GuruFocus considers PharmaNutra SpA to be Modestly Overvalued.
Key valuation signals for MIL:PHN:
OCF Margin %: 5.90% (67% below median its 10-year median of 17.69)
GF Value™: €71.38 vs. price of €88.90 (24.5% above fair value)
Industry Position: 40.7% below the Drug Manufacturers median (#358 of 959)
No single metric tells the full story. See the MIL:PHN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PharmaNutra SpA is a pharmaceutical company. The company is engaged in the research, design, development, and marketing of nutraceutical supplements and medical devices. The products of the company include SiderAL Folic, UltraMag, Cetilar, and others. The company operates in Europe, the Middle East, South America, the Far East, and other regions.
85GF Score
Get the complete analysis for MIL:PHN
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MIL:PHN has been successfully added to your 
